A humanized anti-ganglioside GM2 (GM2) monoclonal antibody with potential antineoplastic and immunomodulating activities. Upon administration, anti-ganglioside GM2 monoclonal antibody BIW-8962 may activate an antibody dependent cellular cytotoxicity (ADCC) against GM2-expressing tumor cells. GM2 is a tumor associated antigen (TAA) overexpressed on the surface of many cancer cells, such as multiple myeloma (MM) cells and neuroblastoma cells.
Download resources about recombinant antibody development and antibody engineering to boost your research.
Select a product category from the dropdown menu below to view related products.
CAT | Product Name | Application | Type |
---|---|---|---|
MOB-406 | Recombinant Anti-GM2 Antibody | ELISA, WB, IF, FuncS | IgG |
MHH-406 | Recombinant Human Anti-GM2 Antibody | WB, Neut, FuncS | IgG |
FAMAB-1396CQ | Mouse Anti-GM2 Recombinant Antibody (clone E1) | ELISA, IHC | Mouse IgG1 |
MOB-102YJL | Mouse Anti-GM2 Recombinant Antibody (clone KM796) | ELISA, ADCC, CDC, FuncS | Mouse IgG1 |
HPAB-A1367-YJ | Human Anti-GM2 Recombinant Antibody (clone KM966) | ELISA, IF, ADCC, CDC, Cyt, FuncS | Chimeric (mouse/human) IgG1 |
There are currently no Customer reviews or questions for Gly-013CL. Click the button above to contact us or submit your feedback about this product.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.